Periodontal disease and diabetes: immunological and clinical interrelationships
DOI:
https://doi.org/10.47196/diab.v47i3.213Keywords:
periodontal disease, diabetesAbstract
In the oral cavity there is a unique situation in our biology: the eruption of the dental organ, which crosses the connective and epithelial tissues creating a continuity solution and a serious risk to health.
As a counterpart to the vulnerability of this critical area, our body has developed a series of highly effective adaptation and defense mechanisms. Still, on many occasions, this barrier is insufficient and a chronic destructive disease of the dental support tissues is established: periodontal disease or periodontitis.
The primary etiology of periodontitis is given by the biofilm or biofilm of bacterial plaque, the presence of which triggers mechanisms of innate immunity that act immediately and induce a specific adaptive response.
References
Brown LJ., Oliver RC., Loe H. Periodontal disease in the US in 1981: prevalence, severity, extent and role in tooth mortality. J Periodontol. 1989; 60:363-370.
Brown LJ., Loe H. Prevalence, extent, severity and progression of periodontal disease. Periodontology 2000, 1993; 2:57-71.
Albandar JM. Underestimation of periodontitis in NHANES surveys. J Periodontol. 2011 Mar; 82 (3):337-341.
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998; 25:134-144.
Krauss JL, Potempa J, Lambris JD, Hajishengallis G. Complementary Tolls in the periodontium: how periodontal bacteria modify complement an TLR responses to prevail in the host. Periodontology 2000. Vol. 52; 2010, 141-162.
Zelkha SA, Freilich RW, Amar S. Periodontal innate inmune mechanisms relevant to aterosclerosis and obesity. Periodontology 2000, Vol. 54, 2010: 207-221
Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011; 38 Suppl 11:60-84.
Papapanou PN. World workshop in clinical periodontics. Periodontal diseases: Epidemiology. Ann Periodontol 1996; 1:1-36.
Tervonen T, Knuuttila M. Relation of diabetes control to periodontal pocketing and alveolar bone level. Oral Surg Oral Med Oral Pathol. 1986; 61:346-349.
Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol. 2001; 28:306-310.
Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997; 68:713-719.
Venza I, Visalli M, Cucinotta M, De Grazia G, Teti D, Venza M. Proinflamatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes. J Periodontol. Jan 2010; 81 (1):99-108.
Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005; 76 (11 Suppl):2106-2115.
Nesse W, Linde A, Abbas F, Spijkervet FK, Dijkstra PU, de Branbander EC, Gerstenbluth I, Vissink A. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol. 2009; 36:295-300.
Mealey BL. Periodontal disease and diabetes. A two-way street. J Am Dent Assoc. 2006 Oct; 137 Suppl:26-31.
Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol. 2003; 74:97-102.
Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology. 2006; 94:10-21.
Slots J. Casual or causal relationship between periodontal infection and non-oral disease? J Dent Res. 77 (10) 1998; 1764-1766.
Scannapieco FA. Position Paper. Periodontal disease as a potential risk factor for systemic diseases. J Periodontol. 1998; 69 (7): 841-850.
Williams RC, Barnett AH, Claffey N, Davis M, Gadsby R, Kellett M, Lip GY, Thackray S. The potential impact of periodontal disease on general health: a consensus view. Curr Med Res Opin 2008; 24:1635-1643.
Rose LF, Genco RJ, Cohen W, Mealey BL. Periodontal Medicine, 2000. B.C. Decker Inc.
Williams RC, Offenbacher S. Periodontal medicine: a new branch of periodontology. Periodontology 2000. 23; 2000, 9-12.
Williams RC. Periodontal disease: the emergence of a new paradigm. Compend Contin Educ Dent. Special Issue. 2001; 22 (2); 3-6.
Slots J, Kamma J. General health risk of periodontal disease. Int Den J 2001; 51:417-427.
Abhijit N Gurav. Periodontitis and Insulin Resistance: Casual or Causal Relationship? Diabetes Metab. J 2012; 36:404-411.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116:1793-1801.
Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med. 1996 Oct; 28 (5): 419-426.
Lalla E., Lamster IB., Drury S., Fu C., Schmidt AM. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontology 2000, 2000, 23; 50-62.
Van Zoelen MA, Achouiti A, van der Poll T. RAGE during infectious diseases. Front Biosci (Schol Ed), 2011 Jun; 1 (3):1119-1132.
Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflamation. Expert Opin Ther Targets 2011 Aug; 15 (8):1023-1035.
Lin L, Park S, Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci 2009 Jan; 1 (14):1403-1413.
Katz J, Wallet S, Cha S. Periodontal disease and the oral-systemic connection: “ Is it all the RAGE?”. Quintessence Int. 2010, 41; 3:229-237.
Yu S, Li H, Ma Y, Fu Y. Matrix metalloproteinase-1 of gingival fibroblasts influenced by AGEs and their association with receptor for AGEs and nuclear factor-kB in gingival connective tissue. J Periodontol. 2012, 83; 1: 119-126.
Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol 2001; 6:113-118.
Jiang SY, Wei CC, Shang TT, Lian Q, Wu CX, Deng JY. High glucose induces inflammatory cytokine through protein kinase C-induced toll-like receptor 2 pathway in gingival fibroblasts. Biochem Biophys Res Commun. 2012 Oct 26; 427 (3):666-670.
Jun HK, Lee SH, Lee HR, Choi BK. Integrin a5b1 activates the NLRP3 inflammasome by direct interaction with a bacterial surface protein. Immunity, 2012 May 25; 36 (5):755-768.
Georgios N. Belibasakis, Anders Johansson. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine, 2012; 59:124-130.
Bostanci N, Meier A, Guggenheim B, Belibasakis GN. Regulation of NLRP3 and AIM2 inflammasome gene expression levels in gingival fibroblasts by oral biofilms. Celular Immunology, 2011; 270: 88-93.
Belibasakis GN, Guggenheim B, Bostanci N. Down-regulation of NLRP3 inflammasome in gingival fibroblasts by subgingival biofilms: Involvement of Porphyromonas gingivalis. Innate Immun. 2013 Feb; 19 (1):3-9.
Grant RW, Dixit VD. Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Front Immunol. 2013; 4:50.
Allen EM, Matthews JB, DJ OH, Griffiths HR, Chapple IL. Oxidative and inflammatory status in type 2 diabetes patients with periodontitis. J Clin Periodontol. 2011; 38:894-901.
Deshpande K, Jain A, Sharma R, Prashar S, Jain R. Diabetes and periodontitis. J Indian Soc Periodontol. 2010 Oct; 14 (4):207-212.
Manouchehr-Pour M., Spagnuolo PJ., Rodman HM., Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol. 1981 Aug; 52 (8):410-415.
Sakallioğlu EE, Ayas B, Lütfioğlu M, Keleş GC, Açikgöz G, Firatli E. Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats. Clin Oral Investig. 2008 Mar; 12(1):83-9.
Gupta M, Chaturvedi R, Jain A. Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine. 2013 Mar; 61 (3):892-7.
Salvi GE, Carollo-Bittel B, Lang NP. Effects of diabetes mellitus on periodontal and peri-implant conditions. Update on associations and risks. J Clin Periodontol. 2008; 35 (Suppl.8): 398-409.
Salvi GE, Beck JD, Offenbacher S. PGE2, IL-1 β and TNFα responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol. 1998 Jul; 3 (1):40-50.
Rees TD. Periodontal management of the patient with diabetes mellitus. Periodontology 2000, 2000; 23:63-72.
Haffajee AD, Socransky SS, Gunsolley JC Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol. 2003 Dec; 8 (1):115-181.
Guerrero A, Griffiths GS, Nibali L, Suvan J, Moles DR, Laurell L, Tonetti MS. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2005 Oct; 32 (10):1096-1107.
Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol. 2001 Apr; 28 (4):296-305.
Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue-destructive enzimes: a potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol. 1993 Aug; 64 (8 Suppl):819-827.
Grossi SG, Skrepcinski FB, De Caro T, Robertson DC, Ho AW, Dunford RG, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997; 68:713-9.
Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol. 1996 Oct; 67(10 Suppl):1094-1102.
Serrano C, Pérez C, Sabogal D Effect of periodontal therapy on metabolic control and an inflammatory mediator in type 2 diabetic subjects: a report on 17 consecutive cases. J Int Acad Periodontol. 2012 Apr; 14 (2):26-34
Tervonen T Knuuttila M, Pohjamo L, Nurkkala H. Immediate response to non-surgical periodontal treatment in subjects with diabetes mellitus. J Clin Periodontol. 1991 Jan; 18 (1): 65-68.
Westfelt E, Rylander H, Blohmé G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996 Feb; 23 (2):92-100.
Karialainen KM, Knuuttila ML, Von Dickhoff KJ. Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol. 1994 Nov; 65 (11):1067-1072.
Chen L, Wei B, Li J, Liu F, Xuan D, Xie B, Zhang J. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes. J Periodontol. 2010 March; 81 (3):364-371.
Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, Koga T. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res. 2004 Jun; 83 (6):485-490.
Donahue RP, Wu T. Insulin resistance and periodontal disease: an epidemiologic overview of research needs and future directions. Ann Periodontol 2001; 6: 119-124.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
